Sympto Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
M&A
Sympto General Information
Description
Developer of a symptom recording tool designed to aid patients in communicating with oncologists. The company's tool provides a weekly questionnaire developed by leading cancer researchers that asks the questions oncologists care most about and visually transmits all the data recorded in the application through a short and easily understood one-pager, enabling oncologists to make informative, proactive, and personalized decisions.
Contact Information
Website
www.symptohealth.comCorporate Office
- 2 Embarcadero Center
- Floor 8
- San Jose, CA 95124
- United States
Corporate Office
- 2 Embarcadero Center
- Floor 8
- San Jose, CA 95124
- United States
Sympto Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 28-Feb-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 06-Mar-2020 | Completed | Product In Beta Test |
Sympto Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 551,172 | $0.000010 | 6% | $0.29 | $0.29 | 1x | $0.29 | 4.22% |
| Seed-1 | 3,594,633 | $0.000010 | 6% | $0.47 | $0.47 | 1x | $0.47 | 27.54% |
Sympto Comparisons
Industry
Financing
Details
Sympto Competitors (3)
One of Sympto’s 3 competitors is Hello Patient, a Venture Capital-Backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hello Patient | Venture Capital-Backed | Austin, TX | ||||
| Care Continuity | Venture Capital-Backed | Dallas, TX | ||||
| Hippocratic AI | Venture Capital-Backed | Palo Alto, CA |
Sympto Signals
Sympto Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Contrary (San Francisco) | Venture Capital | Minority | ||
| Great Oaks Venture Capital | Venture Capital | Minority | ||
| Inflect Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Kleiner Perkins | Venture Capital | Minority |
Sympto Acquisitions (1)
Sympto’s most recent deal was a Merger/Acquisition with Rely. The deal was made on 01-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rely | 01-Mar-2023 | Merger/Acquisition | Other Healthcare Services |
Sympto Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Rely | Emeryville, CA | 2021 |
Sympto FAQs
-
When was Sympto founded?
Sympto was founded in 2017.
-
Where is Sympto headquartered?
Sympto is headquartered in San Jose, CA.
-
What is the size of Sympto?
Sympto has 35 total employees.
-
What industry is Sympto in?
Sympto’s primary industry is Other Healthcare Technology Systems.
-
Is Sympto a private or public company?
Sympto is a Private company.
-
What is Sympto’s current revenue?
The current revenue for Sympto is .
-
How much funding has Sympto raised over time?
Sympto has raised $2.08M.
-
Who are Sympto’s investors?
Contrary (San Francisco), Great Oaks Venture Capital, Inflect Capital, , and Kleiner Perkins are 5 of 7 investors who have invested in Sympto.
-
Who are Sympto’s competitors?
Hello Patient, Care Continuity, and Hippocratic AI are competitors of Sympto.
-
When was Sympto acquired?
Sympto was acquired on 28-Feb-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process